AP1-Luc/EF1α-mCherry Reporter Cell Line - U87MG

The AP1-Luc/EF1α-mCherry reporter cell line (based on U87MG) is a genetically engineered reporter system derived from the human glioblastoma cell line U87MG. U87MG cells are widely used in cancer biology, neuroscience, drug discovery, and signal transduction research because they retain key characteristics of malignant glioma cells and are easily maintained under standard in vitro culture conditions. In this reporter system, an "Activator Protein 1 (AP-1)"-responsive luciferase reporter cassette is integrated into the genome, allowing researchers to monitor the transcriptional activity of AP-1 via luminescent signals. Furthermore, the cell line constitutively expresses the fluorescent protein mCherry under the control of the EF1α promoter, providing a stable fluorescent marker that can be used to assess cell presence, morphology, transduction efficiency, and overall culture quality. This dual-reporter design combines a functional pathway readout with an independent fluorescent signal, facilitating the standardization of experimental data and quality control.

This reporter cell line is suitable for studying AP-1-mediated transcriptional regulation and the signaling pathways that govern AP-1 activation within the context of glioblastoma cells. It can be employed to investigate cellular responses triggered by growth factors, cytokines, stress signals, inflammatory mediators, oncogenic stimuli, and pharmacological compounds. Researchers can utilize this system for compound screening, mechanism-of-action studies, signaling pathway analysis, and the validation of AP-1 inhibitors or activators. The luciferase assay provides a sensitive, quantitative endpoint for high-throughput screening or dose-response experiments, while the mCherry fluorescence allows for rapid monitoring of cell growth, distribution, and experimental consistency. This model also supports research into MAPK, JNK, ERK, and related signaling cascades, and facilitates deeper exploration of the biological properties of gliomas and mechanisms of therapeutic resistance.